MENU
POM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

POM stock forecast, quote, news & analysis

Pomdoctor Ltd is an online medical services platform for chronic diseases in China... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
POM
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for POM with price predictions
Oct 07, 2026

POM saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for POM moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 10 similar instances where the indicator exited the overbought zone. In 10 of the 10 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

POM moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

POM broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for POM entered a downward trend on September 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where POM's RSI Indicator exited the oversold zone, 5 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on POM as a result. In 16 of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for POM just turned positive on September 16, 2026. Looking at past instances where POM's MACD turned positive, the stock continued to rise in 4 of 6 cases over the following month. The odds of a continued upward trend are 67%.

The 10-day moving average for POM crossed bullishly above the 50-day moving average on October 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +17.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where POM advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (1.235). P/E Ratio (0.000) is within average values for comparable stocks, (112.102). POM's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (0.043) is also within normal values, averaging (2.504).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. POM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 60.7M. The market cap for tickers in the group ranges from 36.55K to 14.27B. JDHIF holds the highest valuation in this group at 14.27B. The lowest valued company is PNPL at 36.55K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -6%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was -48%. RDGT experienced the highest price growth at 3%, while SCNX experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -30%. For the same stocks of the Industry, the average monthly volume growth was 150% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 89
Price Growth Rating: 71
SMR Rating: 82
Profit Risk Rating: 100
Seasonality Score: 19 (-100 ... +100)
POM saw its Stochastic Oscillator peaks and leaves the overbought zone